Description
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
Product Unit Size | Cost | Quantity | Stock |
---|
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
Cas No. | 1700693-08-8 |
---|---|
Purity | ≥98% |
Formula | C19H21ClN6O3 |
Formula Wt. | 416.87 |
IUPAC Name | (4-{[5-Chloro-4-(methylamino)-3H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxyphenyl)(4-morpholinyl)methanone |
Synonym | Pyrrolopyrimidine |
Solubility | DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Hatcher J., Zhang J., et al. Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett. 6(5):584-9 (2015). PMID: 26005538.
NSAID; TREK1 K+ potentiator, voltage-gated Na+ ...
PDE5/6 inhibitor.
Steroid lactone produced by Withania somnifera;...
NSAID; COX-1/2 inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Flavanone glycoside found in citrus fruit; SERM...
Steroid hormone, contraceptive; PR agonist.
Nicotinic acid derivative; InhA inhibitor.
Endogenous peptide, involved in paracrine and a...
Insect growth regulator; chitin synthesis inhib...
Docetaxel impurity
AChE and BChE inhibitor.
Endogenous peptide fragment, involved in vasoco...
Selective inhibitor of the γ isoform of PI3K (...
Endogenous opioid peptide; μOR agonist.
Opioid peptide; δOR agonist.
Inert clozapine analog, activates specialized G...
Ca2+-sensing receptor agonist.
MET and Ron inhibitor.
β-lactam; penicillin binding protein inhibitor...